KEGG   ORTHOLOGY: K17454
Entry
K17454                      KO                                     

Name
E2F1
Definition
transcription factor E2F1
Pathway
ko01522  Endocrine resistance
ko04110  Cell cycle
ko04137  Mitophagy - animal
ko04218  Cellular senescence
ko04934  Cushing syndrome
ko05160  Hepatitis C
ko05161  Hepatitis B
ko05163  Human cytomegalovirus infection
ko05165  Human papillomavirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05167  Kaposi sarcoma-associated herpesvirus infection
ko05169  Epstein-Barr virus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05212  Pancreatic cancer
ko05214  Glioma
ko05215  Prostate cancer
ko05218  Melanoma
ko05219  Bladder cancer
ko05220  Chronic myeloid leukemia
ko05222  Small cell lung cancer
ko05223  Non-small cell lung cancer
ko05224  Breast cancer
ko05225  Hepatocellular carcinoma
ko05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09140 Cellular Processes
  09141 Transport and catabolism
   04137 Mitophagy - animal
    K17454  E2F1; transcription factor E2F1
  09143 Cell growth and death
   04110 Cell cycle
    K17454  E2F1; transcription factor E2F1
   04218 Cellular senescence
    K17454  E2F1; transcription factor E2F1
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K17454  E2F1; transcription factor E2F1
   05206 MicroRNAs in cancer
    K17454  E2F1; transcription factor E2F1
  09162 Cancer: specific types
   05212 Pancreatic cancer
    K17454  E2F1; transcription factor E2F1
   05225 Hepatocellular carcinoma
    K17454  E2F1; transcription factor E2F1
   05226 Gastric cancer
    K17454  E2F1; transcription factor E2F1
   05214 Glioma
    K17454  E2F1; transcription factor E2F1
   05220 Chronic myeloid leukemia
    K17454  E2F1; transcription factor E2F1
   05218 Melanoma
    K17454  E2F1; transcription factor E2F1
   05219 Bladder cancer
    K17454  E2F1; transcription factor E2F1
   05215 Prostate cancer
    K17454  E2F1; transcription factor E2F1
   05224 Breast cancer
    K17454  E2F1; transcription factor E2F1
   05222 Small cell lung cancer
    K17454  E2F1; transcription factor E2F1
   05223 Non-small cell lung cancer
    K17454  E2F1; transcription factor E2F1
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K17454  E2F1; transcription factor E2F1
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K17454  E2F1; transcription factor E2F1
   05161 Hepatitis B
    K17454  E2F1; transcription factor E2F1
   05160 Hepatitis C
    K17454  E2F1; transcription factor E2F1
   05163 Human cytomegalovirus infection
    K17454  E2F1; transcription factor E2F1
   05167 Kaposi sarcoma-associated herpesvirus infection
    K17454  E2F1; transcription factor E2F1
   05169 Epstein-Barr virus infection
    K17454  E2F1; transcription factor E2F1
   05165 Human papillomavirus infection
    K17454  E2F1; transcription factor E2F1
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K17454  E2F1; transcription factor E2F1
 09180 Brite Hierarchies
  09182 Protein families: genetic information processing
   03000 Transcription factors
    K17454  E2F1; transcription factor E2F1
Transcription factors [BR:ko03000]
 Eukaryotic type
  Helix-turn-helix
   Fork head/winged helix cell cycle-controlling factors, E2F
    K17454  E2F1; transcription factor E2F1
Genes
HSA: 1869(E2F1)
PTR: 107969994(E2F1)
PPS: 100983073(E2F1)
GGO: 101137595(E2F1)
PON: 100435851(E2F1)
NLE: 100601097(E2F1)
MCC: 714126(E2F1)
MCF: 102146018(E2F1)
CSAB: 103248605(E2F1)
RRO: 104660298(E2F1)
RBB: 108533038(E2F1)
CJC: 100414261(E2F1)
SBQ: 101029045(E2F1)
MMU: 13555(E2f1)
MCAL: 110289983(E2f1)
MPAH: 110318578(E2f1)
RNO: 399489(E2f1)
MUN: 110554547(E2f1)
CGE: 100758556(E2f1)
NGI: 103751571(E2f1)
HGL: 101717980(E2f1)
CCAN: 109690765(E2f1)
OCU: 100356957(E2F1)
TUP: 102484832(E2F1)
CFA: 485839(E2F1)
VVP: 112928157(E2F1)
UMR: 103674455(E2F1)
UAH: 113258272(E2F1)
ORO: 101366721(E2F1)
ELK: 111141556
FCA: 101098454(E2F1)
PTG: 102963506(E2F1)
PPAD: 109272548(E2F1)
AJU: 106974609(E2F1)
BTA: 535369(E2F1)
BOM: 102274863(E2F1)
BIU: 109567683(E2F1)
BBUB: 102390395(E2F1)
CHX: 102173018(E2F1)
OAS: 101117526(E2F1)
SSC: 100153846(E2F1)
CFR: 102517851(E2F1)
CDK: 105092697(E2F1)
BACU: 103015828(E2F1)
LVE: 103070408(E2F1)
OOR: 101275686(E2F1)
DLE: 111184273(E2F1)
PCAD: 102993481(E2F1)
ECB: 100069192(E2F1)
EPZ: 103541516(E2F1)
EAI: 106823225(E2F1)
MYB: 102242618(E2F1)
MYD: 102759026(E2F1)
MNA: 107527747(E2F1)
HAI: 109377242(E2F1)
DRO: 112303722(E2F1)
PALE: 102895276(E2F1)
RAY: 107519491(E2F1)
MJV: 108401113(E2F1)
LAV: 100664468(E2F1)
TMU: 101357348
MDO: 100032280(E2F1)
SHR: 116421696(E2F1)
PCW: 110216806(E2F1)
OAA: 100087014(E2F1)
GGA: 396142(E2F1)
MGP: 100544202(E2F1)
CJO: 107322866(E2F1)
NMEL: 110408351(E2F1)
APLA: 101801576(E2F1)
ACYG: 106047751(E2F1)
TGU: 115497941(E2F1)
LSR: 110475930(E2F1)
SCAN: 103818778(E2F1)
GFR: 102032688(E2F1)
FAB: 101808436(E2F1)
PHI: 102114020(E2F1)
CCAE: 111943945(E2F1)
CCW: 104687904(E2F1)
ETL: 114057267(E2F1)
FPG: 101912302(E2F1)
FCH: 102052559(E2F1)
CLV: 102096538(E2F1)
EGZ: 104124989(E2F1)
NNI: 104019977(E2F1)
PADL: 103912425(E2F1)
AAM: 106496602(E2F1)
ASN: 102379028(E2F1)
AMJ: 102576551(E2F1)
PSS: 102448890(E2F1)
CMY: 102941250(E2F1)
CPIC: 101946215(E2F1)
ACS: 100562223(e2f1)
PVT: 110090563(E2F1)
PBI: 103052541(E2F1)
PMUR: 107294015(E2F1)
TSR: 106550369(E2F1)
PMUA: 114599500(E2F1)
GJA: 107122240(E2F1)
XLA: 100036852(e2f1.L) 108702783(e2f1.S)
XTR: 100493924(e2f1)
NPR: 108786119(E2F1)
DRE: 101885420(e2f1)
CCAR: 109098512(e2f1) 109106942
IPU: 108275488(e2f1)
PHYP: 113530396(e2f1)
AMEX: 103022816(e2f1)
EEE: 113582354(e2f1)
TRU: 101061025(e2f1)
LCO: 104929162(e2f1)
NCC: 104951480(e2f1)
MZE: 101472732(e2f1)
ONL: 100697698(e2f1)
OLA: 101159192(e2f1)
XMA: 102233776(e2f1)
XCO: 114145865(e2f1)
PRET: 103466857(e2f1)
CVG: 107098766(e2f1)
NFU: 107391318(e2f1)
KMR: 108233019(e2f1)
ALIM: 106522384(e2f1)
AOCE: 111571778(e2f1)
CSEM: 103384742(e2f1)
POV: 109630589
LCF: 108882652(e2f1)
SDU: 111230697(e2f1)
SLAL: 111655259(e2f1)
HCQ: 109511673(e2f1)
BPEC: 110158087
MALB: 109967120(e2f1)
ELS: 105022766(e2f1)
SFM: 108939107(e2f1)
PKI: 111842303(e2f1)
LCM: 102358341(E2F1)
CMK: 103188611(e2f1)
RTP: 109915257(e2f1)
 » show all
Reference
PMID:1638634
  Authors
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A
  Title
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.
  Journal
Cell 70:337-50 (1992)
DOI:10.1016/0092-8674(92)90107-N
  Sequence
[hsa:1869]
Reference
  Authors
Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P
  Title
An E2F/miR-20a autoregulatory feedback loop.
  Journal
J Biol Chem 282:2135-43 (2007)
DOI:10.1074/jbc.M608939200
  Sequence
[hsa:1869]
LinkDB

KEGG   ORTHOLOGY: K09389
Entry
K09389                      KO                                     

Name
E2F2
Definition
transcription factor E2F2
Pathway
ko01522  Endocrine resistance
ko04110  Cell cycle
ko04218  Cellular senescence
ko04934  Cushing syndrome
ko05160  Hepatitis C
ko05161  Hepatitis B
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05167  Kaposi sarcoma-associated herpesvirus infection
ko05169  Epstein-Barr virus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05212  Pancreatic cancer
ko05214  Glioma
ko05215  Prostate cancer
ko05218  Melanoma
ko05219  Bladder cancer
ko05220  Chronic myeloid leukemia
ko05222  Small cell lung cancer
ko05223  Non-small cell lung cancer
ko05224  Breast cancer
ko05225  Hepatocellular carcinoma
ko05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K09389  E2F2; transcription factor E2F2
   04218 Cellular senescence
    K09389  E2F2; transcription factor E2F2
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K09389  E2F2; transcription factor E2F2
   05206 MicroRNAs in cancer
    K09389  E2F2; transcription factor E2F2
  09162 Cancer: specific types
   05212 Pancreatic cancer
    K09389  E2F2; transcription factor E2F2
   05225 Hepatocellular carcinoma
    K09389  E2F2; transcription factor E2F2
   05226 Gastric cancer
    K09389  E2F2; transcription factor E2F2
   05214 Glioma
    K09389  E2F2; transcription factor E2F2
   05220 Chronic myeloid leukemia
    K09389  E2F2; transcription factor E2F2
   05218 Melanoma
    K09389  E2F2; transcription factor E2F2
   05219 Bladder cancer
    K09389  E2F2; transcription factor E2F2
   05215 Prostate cancer
    K09389  E2F2; transcription factor E2F2
   05224 Breast cancer
    K09389  E2F2; transcription factor E2F2
   05222 Small cell lung cancer
    K09389  E2F2; transcription factor E2F2
   05223 Non-small cell lung cancer
    K09389  E2F2; transcription factor E2F2
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K09389  E2F2; transcription factor E2F2
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K09389  E2F2; transcription factor E2F2
   05161 Hepatitis B
    K09389  E2F2; transcription factor E2F2
   05160 Hepatitis C
    K09389  E2F2; transcription factor E2F2
   05163 Human cytomegalovirus infection
    K09389  E2F2; transcription factor E2F2
   05167 Kaposi sarcoma-associated herpesvirus infection
    K09389  E2F2; transcription factor E2F2
   05169 Epstein-Barr virus infection
    K09389  E2F2; transcription factor E2F2
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K09389  E2F2; transcription factor E2F2
 09180 Brite Hierarchies
  09182 Protein families: genetic information processing
   03000 Transcription factors
    K09389  E2F2; transcription factor E2F2
Transcription factors [BR:ko03000]
 Eukaryotic type
  Helix-turn-helix
   Fork head/winged helix cell cycle-controlling factors, E2F
    K09389  E2F2; transcription factor E2F2
Genes
HSA: 1870(E2F2)
PTR: 469153(E2F2)
PPS: 100984393(E2F2)
PON: 100458002(E2F2)
NLE: 100583853(E2F2)
MCC: 710200(E2F2)
MCF: 102128093(E2F2)
CSAB: 103225395(E2F2)
RRO: 104656129(E2F2)
RBB: 108538448(E2F2)
CJC: 100414776(E2F2)
SBQ: 101042612(E2F2)
MMU: 242705(E2f2)
MCAL: 110293508(E2f2)
MPAH: 110323461(E2f2)
RNO: 684111(E2f2)
MUN: 110545385(E2f2)
CGE: 100754522(E2f2)
NGI: 103746411(E2f2)
HGL: 101711793(E2f2)
CCAN: 109693815 109693824(E2f2)
OCU: 100346379(E2F2)
TUP: 102479669(E2F2)
CFA: 100855664(E2F2)
VVP: 112930133(E2F2)
AML: 100475779(E2F2)
UMR: 103666789(E2F2)
UAH: 113268523(E2F2)
ORO: 101368301(E2F2)
ELK: 111154729
FCA: 101098067(E2F2)
PTG: 102952251(E2F2)
PPAD: 109274297(E2F2)
AJU: 106977597(E2F2)
BTA: 617024(E2F2)
BOM: 102268181(E2F2)
BIU: 109576116(E2F2)
BBUB: 102403332(E2F2)
CHX: 102186169(E2F2)
OAS: 105606975(E2F2)
SSC: 110261113(E2F2)
CFR: 102515523(E2F2)
CDK: 105088895(E2F2)
BACU: 103017714(E2F2)
LVE: 103081780(E2F2)
OOR: 101286856(E2F2)
DLE: 111163373(E2F2)
PCAD: 102996979
ECB: 100057866(E2F2)
EPZ: 103551301(E2F2)
EAI: 106839983(E2F2)
MYB: 102256714(E2F2)
MYD: 102755439(E2F2)
MNA: 107538329(E2F2)
HAI: 109386699(E2F2)
DRO: 112298997(E2F2)
PALE: 102884459(E2F2)
RAY: 107501037(E2F2)
MJV: 108401353(E2F2)
LAV: 100665816(E2F2)
TMU: 101357556
MDO: 100009746(E2F2)
SHR: 100921594(E2F2)
PCW: 110206051(E2F2)
OAA: 100085053(E2F2)
GGA: 425366(E2F2)
MGP: 100548112(E2F2)
CJO: 107324074(E2F2)
NMEL: 110387486(E2F2)
APLA: 113839791(E2F2)
ACYG: 106045119
TGU: 100223834(E2F2)
LSR: 110472901(E2F2)
SCAN: 103823540
GFR: 102036661(E2F2)
FAB: 101805813(E2F2)
PHI: 102101185(E2F2)
PMAJ: 107214004(E2F2)
CCAE: 111939061
CCW: 104694725
ETL: 114068404(E2F2)
FPG: 101913554(E2F2)
FCH: 102058355(E2F2)
CLV: 102094947(E2F2)
EGZ: 104132520(E2F2)
NNI: 104017698
ACUN: 113488364(E2F2)
AAM: 106486140(E2F2)
ASN: 102375233(E2F2)
AMJ: 109283792(E2F2)
PSS: 102453459(E2F2)
CMY: 102936830(E2F2)
CPIC: 101939699(E2F2)
ACS: 100553413
PVT: 110086160
PBI: 103055008(E2F2)
PMUR: 107302908(E2F2)
TSR: 106552942
PMUA: 114601481(E2F2)
GJA: 107109576(E2F2)
DRE: 568846(si:ch211-160f23.5)
CCAR: 109064982
IPU: 108270354(e2f2)
PHYP: 113544992(e2f2)
AMEX: 103027354
EEE: 113572001
TRU: 101072097(e2f2)
LCO: 104940402(e2f2)
NCC: 104956987(e2f2)
MZE: 101474527(e2f2)
ONL: 100691560(e2f2)
OLA: 101169156(e2f2)
XMA: 102228415(e2f2)
XCO: 114134222(e2f2)
PRET: 103458855(e2f2)
CVG: 107088043(e2f2)
NFU: 107392211(e2f2)
KMR: 108237131(e2f2)
ALIM: 106522405(e2f2)
AOCE: 111573342(e2f2)
CSEM: 103378649(e2f2)
POV: 109628156(e2f2)
LCF: 108875024
SDU: 111225590(e2f2)
SLAL: 111655894(e2f2)
HCQ: 109517212(e2f2)
BPEC: 110172062
MALB: 109955221(e2f2)
SALP: 111968929 112080445(e2f2)
ELS: 105006542(e2f2)
SFM: 108938635(e2f2)
PKI: 111859627(e2f2)
LCM: 102353099(E2F2)
CMK: 103179524
RTP: 109929351
AME: 412770
BIM: 100741567
BTER: 100647151
CCAL: 108629580
OBB: 114880933
SOC: 105203774
MPHA: 105831652
AEC: 105153819
ACEP: 105624414
PBAR: 105423207
VEM: 105560358
HST: 105184549
DQU: 106742780
CFO: 105252305
PGC: 109857267
OBO: 105286649
PCF: 106788716
NVI: 100123437
CSOL: 105362866
MDL: 103575408
TCA: 656396
DPA: 109542741
ATD: 109602516
NVL: 108569396
BMOR: 100216494(E2f1)
BMAN: 114250266
PMAC: 106707875
PRAP: 110995274
HAW: 110371803
TNL: 113492891
PXY: 105381100
API: 100163786
DNX: 107167183
AGS: 114128200
RMD: 113552257
BTAB: 109042413
ZNE: 110828766
FCD: 110843070
PVM: 113815959
PTEP: 107453668
HMG: 100201375
 » show all
Reference
PMID:8246995
  Authors
Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC
  Title
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F.
  Journal
Mol Cell Biol 13:7802-12 (1993)
DOI:10.1128/MCB.13.12.7802
  Sequence
[hsa:1870]
LinkDB

KEGG   ORTHOLOGY: K06620
Entry
K06620                      KO                                     

Name
E2F3
Definition
transcription factor E2F3
Pathway
ko01522  Endocrine resistance
ko04110  Cell cycle
ko04218  Cellular senescence
ko04934  Cushing syndrome
ko05160  Hepatitis C
ko05161  Hepatitis B
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05167  Kaposi sarcoma-associated herpesvirus infection
ko05169  Epstein-Barr virus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05212  Pancreatic cancer
ko05214  Glioma
ko05215  Prostate cancer
ko05218  Melanoma
ko05219  Bladder cancer
ko05220  Chronic myeloid leukemia
ko05222  Small cell lung cancer
ko05223  Non-small cell lung cancer
ko05224  Breast cancer
ko05225  Hepatocellular carcinoma
ko05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K06620  E2F3; transcription factor E2F3
   04218 Cellular senescence
    K06620  E2F3; transcription factor E2F3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K06620  E2F3; transcription factor E2F3
   05206 MicroRNAs in cancer
    K06620  E2F3; transcription factor E2F3
  09162 Cancer: specific types
   05212 Pancreatic cancer
    K06620  E2F3; transcription factor E2F3
   05225 Hepatocellular carcinoma
    K06620  E2F3; transcription factor E2F3
   05226 Gastric cancer
    K06620  E2F3; transcription factor E2F3
   05214 Glioma
    K06620  E2F3; transcription factor E2F3
   05220 Chronic myeloid leukemia
    K06620  E2F3; transcription factor E2F3
   05218 Melanoma
    K06620  E2F3; transcription factor E2F3
   05219 Bladder cancer
    K06620  E2F3; transcription factor E2F3
   05215 Prostate cancer
    K06620  E2F3; transcription factor E2F3
   05224 Breast cancer
    K06620  E2F3; transcription factor E2F3
   05222 Small cell lung cancer
    K06620  E2F3; transcription factor E2F3
   05223 Non-small cell lung cancer
    K06620  E2F3; transcription factor E2F3
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K06620  E2F3; transcription factor E2F3
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K06620  E2F3; transcription factor E2F3
   05161 Hepatitis B
    K06620  E2F3; transcription factor E2F3
   05160 Hepatitis C
    K06620  E2F3; transcription factor E2F3
   05163 Human cytomegalovirus infection
    K06620  E2F3; transcription factor E2F3
   05167 Kaposi sarcoma-associated herpesvirus infection
    K06620  E2F3; transcription factor E2F3
   05169 Epstein-Barr virus infection
    K06620  E2F3; transcription factor E2F3
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K06620  E2F3; transcription factor E2F3
 09180 Brite Hierarchies
  09182 Protein families: genetic information processing
   03000 Transcription factors
    K06620  E2F3; transcription factor E2F3
Transcription factors [BR:ko03000]
 Eukaryotic type
  Helix-turn-helix
   Fork head/winged helix cell cycle-controlling factors, E2F
    K06620  E2F3; transcription factor E2F3
Genes
HSA: 1871(E2F3)
PTR: 471865(E2F3)
PPS: 100986032(E2F3)
GGO: 101138211(E2F3)
PON: 100448297(E2F3)
NLE: 100594018(E2F3)
MCC: 713904(E2F3)
MCF: 102138138(E2F3)
CSAB: 103222084(E2F3)
RRO: 104654803(E2F3)
RBB: 108522131(E2F3)
CJC: 100390235(E2F3)
SBQ: 101034207(E2F3)
MMU: 13557(E2f3)
MCAL: 110308034(E2f3)
MPAH: 110333784(E2f3)
RNO: 291105(E2f3)
CGE: 100754647(E2f3)
NGI: 103745641(E2f3)
HGL: 101698963(E2f3)
CCAN: 109697329(E2f3)
OCU: 100353173(E2F3)
TUP: 102499416(E2F3)
CFA: 488239(E2F3)
VVP: 112920427(E2F3)
AML: 100484544(E2F3)
UMR: 103678383(E2F3)
UAH: 113264513(E2F3)
ORO: 101371945(E2F3)
ELK: 111138625
FCA: 101089768(E2F3)
PTG: 102948948(E2F3)
PPAD: 109252691(E2F3)
AJU: 106987605(E2F3)
BTA: 541184(E2F3)
BOM: 102270876(E2F3)
BIU: 109577245(E2F3)
BBUB: 102394305(E2F3)
CHX: 102169535(E2F3)
OAS: 101121809(E2F3)
SSC: 100154407(E2F3)
CFR: 102513737(E2F3)
CDK: 105089193(E2F3)
BACU: 103007760(E2F3)
LVE: 103085882(E2F3)
OOR: 101269392(E2F3)
DLE: 111181407(E2F3)
PCAD: 102976146(E2F3)
ECB: 100052248(E2F3)
EPZ: 103549781(E2F3)
EAI: 106847694(E2F3)
MYB: 102259711(E2F3)
MYD: 102768307(E2F3)
MNA: 107539632(E2F3)
HAI: 109381623(E2F3)
DRO: 112309256(E2F3)
PALE: 102887239(E2F3)
RAY: 107501692(E2F3)
MJV: 108401143(E2F3)
LAV: 100656140(E2F3)
TMU: 101346679
MDO: 100017977(E2F3)
SHR: 100934669(E2F3)
PCW: 110208713(E2F3)
OAA: 100090475(E2F3)
GGA: 420824(E2F3)
MGP: 100549000
CJO: 107309724(E2F3)
NMEL: 110394214(E2F3)
APLA: 101793883(E2F3)
ACYG: 106041729(E2F3)
TGU: 100218382(E2F3)
LSR: 110483450(E2F3)
SCAN: 103819403(E2F3)
GFR: 102039591(E2F3)
FAB: 101815458(E2F3)
PHI: 102099157(E2F3)
PMAJ: 107200762(E2F3)
CCAE: 111923737(E2F3)
CCW: 104691435(E2F3)
ETL: 114065736(E2F3)
FPG: 101918557(E2F3)
FCH: 102046119(E2F3)
CLV: 102089870(E2F3)
EGZ: 104125451(E2F3)
NNI: 104021799(E2F3)
ACUN: 113477352(E2F3)
PADL: 103919104(E2F3)
AAM: 106500319(E2F3)
ASN: 102387519(E2F3)
AMJ: 102560678(E2F3)
PSS: 102446755(E2F3)
CMY: 102933240(E2F3)
CPIC: 101939961(E2F3)
ACS: 100551868(e2f3)
PVT: 110072925(E2F3)
PBI: 103055302(E2F3)
PMUR: 107302570(E2F3)
TSR: 106548848(E2F3)
PMUA: 114600853(E2F3)
GJA: 107121911(E2F3)
XLA: 108719151(e2f3.L) 398159(e2f3.S)
XTR: 496522(e2f3)
NPR: 108786389(E2F3)
DRE: 791146(e2f3)
IPU: 108272398 108275414(e2f3)
PHYP: 113533712(e2f3) 113543874
AMEX: 103022559 103038273(e2f3)
EEE: 113583586 113587067(e2f3)
TRU: 101079212(e2f3) 105417145
LCO: 104920190(e2f3) 104936242
NCC: 104941105(e2f3)
MZE: 101464453(e2f3) 101479374
ONL: 100698567(e2f3) 100704871
OLA: 101154792 101158132(e2f3)
XMA: 102227367(e2f3) 102238348
XCO: 114142331(e2f3) 114155341
PRET: 103472053 103478383(e2f3)
CVG: 107080887 107090496(e2f3)
NFU: 107374299 107378737(e2f3)
KMR: 108232188(e2f3) 108238723
ALIM: 106521601(e2f3) 106526948
AOCE: 111572932(e2f3) 111579067
CSEM: 103388290(e2f3) 103394109
POV: 109631749 109632164(e2f3)
LCF: 108889207(e2f3) 108900426
SDU: 111227830(e2f3) 111233204
SLAL: 111657207(e2f3) 111671419
HCQ: 109517659(e2f3) 109519227
BPEC: 110167309 110171730(e2f3)
MALB: 109958294(e2f3) 109970528
OTW: 112238727
SALP: 111977498(e2f3) 112076299
ELS: 105007462(e2f3) 105030233
SFM: 108919264(e2f3) 108940634
PKI: 111844317 111852468(e2f3)
LCM: 102355481(E2F3)
CMK: 103184907(e2f3)
RTP: 109923152(e2f3)
BFO: 118404549
CIN: 778584(e2f1/2/3/6)
SPU: 762571(E2E3)
APLC: 110978256
DME: Dmel_CG6376(E2f1)
DER: 6553411
DSE: 6614332
DSI: Dsimw501_GD19970(Dsim_GD19970)
DSR: 110188319
DPE: 6591452
DMN: 108155659
DWI: 6647993
DAZ: 108621685
DNV: 108658061
DHE: 111600848
MDE: 101899368
LCQ: 111676161
AAG: 5576834
TUT: 107368690
CSCU: 111620283
BMY: Bm1_00365
MYI: 110465804
OBI: 106883944
LAK: 106175980
ADF: 107344047
AMIL: 114966926
PDAM: 113683149
SPIS: 111343325
DGT: 114527505
AQU: 100636697
ATH: AT1G47870(ATE2F2) AT2G36010(E2F3) AT5G22220(E2F1)
LJA: Lj1g3v2156580.2(Lj1g3v2156580.2) Lj3g3v2949670.1(Lj3g3v2949670.1) Lj3g3v2949670.2(Lj3g3v2949670.2) Lj5g3v0816340.1(Lj5g3v0816340.1)
DOSA: Os02t0537500-01(Os02g0537500) Os04t0112200-00(Os04g0112200) Os04t0416100-01(Os04g0416100) Os12t0158800-01(Os12g0158800)
ATS: 109732644(LOC109732644) 109753167(LOC109753167) 109763537(LOC109763537) 109768933(LOC109768933)
CRE: CHLREDRAFT_206364(E2F1)
VCN: VOLCADRAFT_127253(e2f1)
DDI: DDB_G0284129(E2F)
DFA: DFA_08107
CPV: cgd1_1560
SPAR: SPRG_02714
 » show all
Reference
PMID:8246996
  Authors
Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K
  Title
The retinoblastoma protein binds to a family of E2F transcription factors.
  Journal
Mol Cell Biol 13:7813-25 (1993)
DOI:10.1128/MCB.13.12.7813
  Sequence
[hsa:1871]
LinkDB

DBGET integrated database retrieval system